No Data
No Data
raily aesmed (02135) fell by 38.00%, now trading at 0.098 yuan, hitting a 52-week low.
As of 11:36, raily aesmed (02135) fell by 38.00% compared to the previous closing price, now trading at 0.098 yuan, hitting a 52-week low; volume of 0.04 million shares, turnover of 0.0039 million Hong Kong dollars.
RAILY AESMED: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024
Raily Aesmed (02135.HK) held a board of directors meeting on August 30 to consider and approve the mid-term performance.
Raily aesmed (02135.HK) announced that the board of directors meeting will be held on Friday, August 30, 2024, to consider and approve the unaudited interim performance of the group for the six months ending June 30, 2024, including publication, and to consider declaring, recommending or paying dividends (if any).
Express News | Raily Aesthetic Medicine International - Pursuant to Termination, Existing Shareholders and Target Co Shall Refund RMB20.0 Mln
Express News | Raily Aesthetic Medicine International - Termination of Discloseable Transaction in Relation to Capital Injection
Raily aesmed (02135.HK) issued a warning about the expected net loss of 2 million yuan in the first half of the year.
On August 7th, Gelonhui reported that the Board of Directors of Raily Aesmed (02135.HK) anticipates that the Group will record: (i) revenue of approximately RMB 0.117 billion for the six months ending on June 30, 2024; and (ii) a loss attributable to owners of the parent company of approximately RMB 2 million for the six months ending on June 30, 2024 (for the 6 months ending on June 30, 2023, the loss attributable to owners of the parent company was approximately RMB 2 million). The Board of Directors believes that the continuous losses are mainly due to the following reasons: (a) in order to accelerate the research and development and production of the group's medical instruments products, the group has increased indirect investment in the company.
No Data
No Data